Cargando…
The fiscal value of human lives lost from coronavirus disease (COVID-19) in China
OBJECTIVE: According to the WHO coronavirus disease (COVID-19) situation report 35, as of 24th February 2020, there was a total of 77,262 confirmed COVID-19 cases in China. That included 2595 deaths. The specific objective of this study was to estimate the fiscal value of human lives lost due to COV...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110291/ https://www.ncbi.nlm.nih.gov/pubmed/32238182 http://dx.doi.org/10.1186/s13104-020-05044-y |
_version_ | 1783513026860679168 |
---|---|
author | Kirigia, Joses M. Muthuri, Rose Nabi Deborah Karimi |
author_facet | Kirigia, Joses M. Muthuri, Rose Nabi Deborah Karimi |
author_sort | Kirigia, Joses M. |
collection | PubMed |
description | OBJECTIVE: According to the WHO coronavirus disease (COVID-19) situation report 35, as of 24th February 2020, there was a total of 77,262 confirmed COVID-19 cases in China. That included 2595 deaths. The specific objective of this study was to estimate the fiscal value of human lives lost due to COVID-19 in China as of 24th February 2020. RESULTS: The deaths from COVID-19 had a discounted (at 3%) total fiscal value of Int$ 924,346,795 in China. Out of which, 63.2% was borne by people aged 25–49 years, 27.8% by people aged 50–64 years, and 9.0% by people aged 65 years and above. The average fiscal value per death was Int$ 356,203. Re-estimation of the economic model alternately with 5% and 10 discount rates led to a reduction in the expected total fiscal value by 21.3% and 50.4%, respectively. Furthermore, the re-estimation of the economic model using the world’s highest average life expectancy of 87.1 years (which is that of Japanese females), instead of the national life expectancy of 76.4 years, increased the total fiscal value by Int$ 229,456,430 (24.8%). |
format | Online Article Text |
id | pubmed-7110291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71102912020-04-01 The fiscal value of human lives lost from coronavirus disease (COVID-19) in China Kirigia, Joses M. Muthuri, Rose Nabi Deborah Karimi BMC Res Notes Research Note OBJECTIVE: According to the WHO coronavirus disease (COVID-19) situation report 35, as of 24th February 2020, there was a total of 77,262 confirmed COVID-19 cases in China. That included 2595 deaths. The specific objective of this study was to estimate the fiscal value of human lives lost due to COVID-19 in China as of 24th February 2020. RESULTS: The deaths from COVID-19 had a discounted (at 3%) total fiscal value of Int$ 924,346,795 in China. Out of which, 63.2% was borne by people aged 25–49 years, 27.8% by people aged 50–64 years, and 9.0% by people aged 65 years and above. The average fiscal value per death was Int$ 356,203. Re-estimation of the economic model alternately with 5% and 10 discount rates led to a reduction in the expected total fiscal value by 21.3% and 50.4%, respectively. Furthermore, the re-estimation of the economic model using the world’s highest average life expectancy of 87.1 years (which is that of Japanese females), instead of the national life expectancy of 76.4 years, increased the total fiscal value by Int$ 229,456,430 (24.8%). BioMed Central 2020-04-01 /pmc/articles/PMC7110291/ /pubmed/32238182 http://dx.doi.org/10.1186/s13104-020-05044-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Note Kirigia, Joses M. Muthuri, Rose Nabi Deborah Karimi The fiscal value of human lives lost from coronavirus disease (COVID-19) in China |
title | The fiscal value of human lives lost from coronavirus disease (COVID-19) in China |
title_full | The fiscal value of human lives lost from coronavirus disease (COVID-19) in China |
title_fullStr | The fiscal value of human lives lost from coronavirus disease (COVID-19) in China |
title_full_unstemmed | The fiscal value of human lives lost from coronavirus disease (COVID-19) in China |
title_short | The fiscal value of human lives lost from coronavirus disease (COVID-19) in China |
title_sort | fiscal value of human lives lost from coronavirus disease (covid-19) in china |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110291/ https://www.ncbi.nlm.nih.gov/pubmed/32238182 http://dx.doi.org/10.1186/s13104-020-05044-y |
work_keys_str_mv | AT kirigiajosesm thefiscalvalueofhumanliveslostfromcoronavirusdiseasecovid19inchina AT muthurirosenabideborahkarimi thefiscalvalueofhumanliveslostfromcoronavirusdiseasecovid19inchina AT kirigiajosesm fiscalvalueofhumanliveslostfromcoronavirusdiseasecovid19inchina AT muthurirosenabideborahkarimi fiscalvalueofhumanliveslostfromcoronavirusdiseasecovid19inchina |